Entecavir tablets are indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
From the U.S. FDA-approved label for Entecavir. Full label: DailyMed.
Entecavir tablets are indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
From the U.S. FDA-approved label for Entecavir. Full label: DailyMed.
Nucleoside-inhibitor-treatment-naïve with compensated liver disease (greater than or equal to 16 years old): 0.5 mg once daily. Nucleoside-inhibitor-treatment-naïve and lamivudine-experienced pediatric patients at least 2 years of age and weighing at least 10 kg: dosing is based on weight. Lamivudine-refractory or known lamivudine or telbivudine resistance substitutions (greater than or equal to 16 years old): 1 mg once daily.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Severe acute exacerbations of hepatitis B virus infection after discontinuation: Monitor hepatic function closely for at least several months. Co-infection with HIV: Entecavir is not recommended unless the patient is also receiving HAART. Lactic acidosis and severe hepatomegaly with steatosis: If suspected, treatment should be suspended. 5.1 Severe Acute Exacerbations of Hepatitis B Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in other sections of the labeling: Exacerbations of hepatitis after discontinuation of treatment. Lactic acidosis and severe hepatomegaly with steatosis. In adults, the most common adverse reactions (≥3%, all severity grades) are headache, fatigue, dizziness, and nausea. The adverse reactions observed in pediatric patients were consistent with those observed in adults.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
34 products from 25 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| ACECAVIR 0.5mg Tablet | Entecavir (0.5mg) | Nova Genetica Pvt. Ltd. | |
| Entaliv 0.5 0.5mg Tablet | Entecavir (0.5mg) | Dr. Reddy's Laboratories. | |
| Entavir 0.5 0.5mg Tablet | Entecavir (0.5mg) | Cipla Ltd. | |
| Enteca 0.5 0.5mg Tablet | Entecavir (0.5mg) | Ranbaxy Laboratories Ltd. | |
| Enteca 1 1mg Tablet | Entecavir (1mg) | Ranbaxy Laboratories Ltd. | |
| Gunavir Tablet | Entecavir | QbD Pharmaceuticals | |
| X-VIR 0.5mg Tablet | Entecavir (0.5mg) | Natco Pharma | |
| Anticanol 0.5 Tablet | Entecavir (0.5mg) | Knoll Pharmaceuticals Ltd | strip of 10 tablets |
| Austavir 0.5 Tablet | Entecavir (0.5mg) | Care Formulation Labs Pvt Ltd | strip of 10 tablets |
| Austavir 1mg Tablet | Entecavir (1mg) | Care Formulation Labs Pvt Ltd | strip of 10 tablets |
| Baraclude 1mg Tablet | Entecavir (1mg) | BMS India Pvt Ltd | strip of 10 tablets |
| Cgtec 0.5mg Tablet | Entecavir (0.5mg) | Cmg Biotech Pvt Ltd | strip of 10 tablets |
| Cronivir Tablet | Entecavir (0.5mg) | Hetero Drugs Ltd | bottle of 30 tablets |
| E-Vir Tablet | Entecavir (0.5mg) | Waterley Pharmaceuticals Pvt Ltd | bottle of 30 tablets |
| Encarvir 0.5mg Tablet | Entecavir (0.5mg) | Vestal Healthcare | strip of 10 tablets |
| Encure Tablet | Entecavir (0.5mg) | Emcure Pharmaceuticals Ltd | strip of 10 tablets |
| Entabest 0.5 Tablet | Entecavir (0.5mg) | Shelton Pharmaceuticals Pvt Ltd | bottle of 30 tablets |
| Entacover 0.5 Tablet | Entecavir (0.5mg) | Steris Healthcare Pvt Ltd | strip of 10 tablets |
| Entaliv 0.5 Tablet | Entecavir (0.5mg) | Dr Reddy's Laboratories Ltd | strip of 30 tablets |
| Entarica 0.5 Tablet | Entecavir (0.5mg) | Fibrica Healthcare Pvt Ltd | bottle of 30 tablets |
| Entarica 1 Tablet | Entecavir (1mg) | Fibrica Healthcare Pvt Ltd | bottle of 30 tablets |
| Entarica 1mg Tablet | Entecavir (1mg) | Fibrica Healthcare Pvt Ltd | strip of 10 tablets |
| Entavir 0.5mg Tablet | Entecavir (0.5mg) | Cipla Ltd | strip of 10 tablets |
| Entavir 1mg Tablet | Entecavir (1mg) | Cipla Ltd | strip of 10 tablets |
| Entehep 0.5 Tablet | Entecavir (0.5mg) | Zydus Cadila | bottle of 30 tablets |
| Entehep 1 Tablet | Entecavir (1mg) | Zydus Cadila | bottle of 30 tablets |
| Entimate 0.5 Tablet | Entecavir (0.5mg) | RSL Bioscience Pvt Ltd | strip of 10 tablets |
| Entimate Tablet | Entecavir (0.5mg) | RSL Bioscience Pvt Ltd | bottle of 30 tablets |
| Frithvir 0.5mg Tablet | Entecavir (0.5mg) | La Renon Healthcare Pvt Ltd | strip of 10 tablets |
| Gepatit Tablet | Entecavir (0.5mg) | Mylan Pharmaceuticals Pvt Ltd | strip of 10 tablets |
Showing 30 of 34 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Entecavir tablets, USP should be stored in a tightly closed container at 20° to 25°C (68° to 77°F); Protect from light.
Storage information from the U.S. FDA-approved label.
Entecavir is recorded in the NepalDoc medicine catalog for: Chronic hepatitis B.
For Chronic hepatitis B: Lamivudine (3TC), Tenofovir disoproxil fumarate (TDF).
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
